Period,symbol,NAV,sharesOutstanding,researchDevelopment,effectOfAccountingCharges,incomeBeforeTax,minorityInterest,netIncome,sellingGeneralAdministrative,grossProfit,ebit,operatingIncome,otherOperatingExpenses,interestExpense,extraordinaryItems,nonRecurring,otherItems,incomeTaxExpense,totalRevenue,totalOperatingExpenses,costOfRevenue,totalOtherIncomeExpenseNet,discontinuedOperations,netIncomeFromContinuingOps,netIncomeApplicableToCommonShares,intangibleAssets,capitalSurplus,totalLiab,totalStockholderEquity,otherCurrentLiab,totalAssets,commonStock,retainedEarnings,otherLiab,otherAssets,cash,totalCurrentLiabilities,propertyPlantEquipment,totalCurrentAssets,netReceivables,inventory,accountsPayable,longTermInvestments,longTermDebt,changeToLiabilities,totalCashflowsFromInvestingActivities,totalCashFromFinancingActivities,changeToOperatingActivities,issuanceOfStock,changeInCash,totalCashFromOperatingActivities,depreciation,otherCashflowsFromInvestingActivities,changeToInventory,changeToAccountReceivables,changeToNetincome,investments,netBorrowings,otherCashflowsFromFinancingActivities,capitalExpenditures,WC,language,region,quoteType,triggerable,quoteSourceName,currency,market,regularMarketPrice,regularMarketTime,regularMarketChange,regularMarketOpen,regularMarketDayHigh,regularMarketDayLow,regularMarketVolume,shortName,exchange,marketState,twoHundredDayAverageChangePercent,exchangeDataDelayedBy,esgPopulated,tradeable,regularMarketChangePercent,regularMarketDayRange,regularMarketPreviousClose,bid,ask,bidSize,askSize,messageBoardId,fullExchangeName,longName,financialCurrency,averageDailyVolume3Month,averageDailyVolume10Day,fiftyTwoWeekLowChange,fiftyTwoWeekLowChangePercent,fiftyTwoWeekRange,fiftyTwoWeekHighChange,fiftyTwoWeekHighChangePercent,fiftyTwoWeekLow,fiftyTwoWeekHigh,dividendDate,earningsTimestamp,earningsTimestampStart,earningsTimestampEnd,priceHint,epsCurrentYear,priceEpsCurrentYear,fiftyDayAverage,fiftyDayAverageChange,fiftyDayAverageChangePercent,twoHundredDayAverage,twoHundredDayAverageChange,marketCap,sourceInterval,exchangeTimezoneName,exchangeTimezoneShortName,gmtOffSetMilliseconds,Beta (5Y Monthly),52-Week Change 3,S&P500 52-Week Change 3,52 Week High 3,52 Week Low 3,50-Day Moving Average 3,200-Day Moving Average 3,Avg Vol (3 month) 3,Avg Vol (10 day) 3,Shares Outstanding 5,Implied Shares Outstanding 6,Float,% Held by Insiders 1,% Held by Institutions 1,"Shares Short (May 27, 2021) 4","Short Ratio (May 27, 2021) 4","Short % of Float (May 27, 2021) 4","Short % of Shares Outstanding (May 27, 2021) 4","Shares Short (prior month Apr 29, 2021) 4",Forward Annual Dividend Rate 4,Forward Annual Dividend Yield 4,Trailing Annual Dividend Rate 3,Trailing Annual Dividend Yield 3,5 Year Average Dividend Yield 4,Payout Ratio 4,Dividend Date 3,Ex-Dividend Date 4,Last Split Factor 2,Last Split Date 3,Fiscal Year Ends,Most Recent Quarter (mrq),Profit Margin,Operating Margin (ttm),Return on Assets (ttm),Return on Equity (ttm),Revenue (ttm),Revenue Per Share (ttm),Quarterly Revenue Growth (yoy),Gross Profit (ttm),EBITDA,Net Income Avi to Common (ttm),Diluted EPS (ttm),Quarterly Earnings Growth (yoy),Total Cash (mrq),Total Cash Per Share (mrq),Total Debt (mrq),Total Debt/Equity (mrq),Current Ratio (mrq),Book Value Per Share (mrq),Operating Cash Flow (ttm),Levered Free Cash Flow (ttm),index,zip,sector,fullTimeEmployees,longBusinessSummary,city,phone,state,compensationAsOfEpochDate,country,website,maxAge,address1,industry
t0,INVO,5475000.0,10449000,66267,,-2453469,,-2453469,2115303,624209,-1559792,-1559792,,-895226,,,,0,684523,2244315,60314,-893677,,-2453469,-2453469,123491.0,40287000.0,4591688.0,5598491.0,714286.0,10190179.0,1042.0,-34689551.0,2679040.0,280160.0,8423236.0,1859859.0,203323.0,9583205.0,527651.0,268349.0,446847.0,,,4545.0,-308980.0,369840.0,-213865.0,369840.0,-1674524.0,-1735384.0,8654.0,-280000.0,-2977.0,-505952.0,568587.0,,,,,7723346.0,en-US,US,EQUITY,True,Delayed Quote,USD,us_market,3.92,1630526403,0.07000017,3.92,3.9215,3.8,12610,"INVO BioScience, Inc.",NCM,PRE,-0.08072854,0,False,False,1.8181863,3.8 - 3.9215,3.85,0.0,0.0,11,13,finmb_51592503,NasdaqCM,"INVO Bioscience, Inc.",USD,41364,25400,1.02,0.35172412,2.9 - 12.3,-8.38,-0.6813008,2.9,12.3,1604880000,1617134400,1617134400,1617134400,4,-0.78,-5.0256414,4.1314287,-0.21142864,-0.051175673,4.2642465,-0.3442464,40960080,15,America/New_York,EDT,-14400000,-1.15,,,12.3,2.9,4.1314,4.2642,41.36k,25.4k,10.45M,,8.22M,18.04%,15.72%,294.8k,4.88,2.90%,2.82%,316.08k,,,,,,0.00%,"Nov 08, 2020",,5:8,"Nov 08, 2020","Dec 30, 2020","Mar 30, 2021",0.00%,-388.06%,-63.67%,"-1,608.40%",1.46M,0.22,164.70%,958.25k,-5.67M,-9.36M,,,8.42M,0.81,418.93k,7.48,5.15,,-5.65M,-1.82M,Value,34240,Healthcare,10,"INVO Bioscience, Inc., a medical device company, provides assisted reproductive technology solutions worldwide. It offers INVOcell, a patented intravaginal culture system used for the natural in vivo incubation of eggs and sperm during fertilization and early embryo development. The company was founded in 2007 and is based in Sarasota, Massachusetts.",Sarasota,978 878 9505,FL,1609372800,United States,http://www.invobioscience.com,86400,5582 Broadcast Court,Medical Devices
t-1,INVO,5648143.0,10449000,220934,,-3808180,,-3808216,1753194,196099,-1787754,-1787754,,-2024616,,,,36,196572,1984326,473,-2020426,,-3808216,-3808216,94963.0,37978224.0,5204237.0,5743106.0,715348.0,10947343.0,964.0,-32236082.0,2857612.0,240.0,10097760.0,2287991.0,211525.0,10542531.0,21699.0,265372.0,263730.0,98084.0,,-305586.0,-96572.0,11106368.0,-46316.0,11475052.0,9189471.0,-1820325.0,8613.0,-240.0,-23888.0,-18000.0,555813.0,-65410.0,-475000.0,106316.0,-28733.0,8254540.0,en-US,US,EQUITY,True,Delayed Quote,USD,us_market,3.92,1630526403,0.07000017,3.92,3.9215,3.8,12610,"INVO BioScience, Inc.",NCM,PRE,-0.08072854,0,False,False,1.8181863,3.8 - 3.9215,3.85,0.0,0.0,11,13,finmb_51592503,NasdaqCM,"INVO Bioscience, Inc.",USD,41364,25400,1.02,0.35172412,2.9 - 12.3,-8.38,-0.6813008,2.9,12.3,1604880000,1617134400,1617134400,1617134400,4,-0.78,-5.0256414,4.1314287,-0.21142864,-0.051175673,4.2642465,-0.3442464,40960080,15,America/New_York,EDT,-14400000,-1.15,,,12.3,2.9,4.1314,4.2642,41.36k,25.4k,10.45M,,8.22M,18.04%,15.72%,294.8k,4.88,2.90%,2.82%,316.08k,,,,,,0.00%,"Nov 08, 2020",,5:8,"Nov 08, 2020","Dec 30, 2020","Mar 30, 2021",0.00%,-388.06%,-63.67%,"-1,608.40%",1.46M,0.22,164.70%,958.25k,-5.67M,-9.36M,,,8.42M,0.81,418.93k,7.48,5.15,,-5.65M,-1.82M,Value,34240,Healthcare,10,"INVO Bioscience, Inc., a medical device company, provides assisted reproductive technology solutions worldwide. It offers INVOcell, a patented intravaginal culture system used for the natural in vivo incubation of eggs and sperm during fertilization and early embryo development. The company was founded in 2007 and is based in Sarasota, Massachusetts.",Sarasota,978 878 9505,FL,1609372800,United States,http://www.invobioscience.com,86400,5582 Broadcast Court,Medical Devices
t-2,INVO,-3995170.0,10449000,112552,,-1771827,,-1771827,1463887,308673,-1267766,-1267766,,-504061,,,,0,336071,1603837,27398,-504061,,-1771827,-1771827,93226.0,24525427.0,5590936.0,-3901944.0,714286.0,1688992.0,495.0,-28427866.0,3036147.0,,908289.0,1882832.0,190953.0,1372139.0,3699.0,241484.0,450222.0,32674.0,607521.0,-32054.0,-60952.0,405699.0,39438.0,11475052.0,-595662.0,-940409.0,8812.0,-240.0,2624.0,67500.0,330000.0,-32674.0,512015.0,-106316.0,-28733.0,-510693.0,en-US,US,EQUITY,True,Delayed Quote,USD,us_market,3.92,1630526403,0.07000017,3.92,3.9215,3.8,12610,"INVO BioScience, Inc.",NCM,PRE,-0.08072854,0,False,False,1.8181863,3.8 - 3.9215,3.85,0.0,0.0,11,13,finmb_51592503,NasdaqCM,"INVO Bioscience, Inc.",USD,41364,25400,1.02,0.35172412,2.9 - 12.3,-8.38,-0.6813008,2.9,12.3,1604880000,1617134400,1617134400,1617134400,4,-0.78,-5.0256414,4.1314287,-0.21142864,-0.051175673,4.2642465,-0.3442464,40960080,15,America/New_York,EDT,-14400000,-1.15,,,12.3,2.9,4.1314,4.2642,41.36k,25.4k,10.45M,,8.22M,18.04%,15.72%,294.8k,4.88,2.90%,2.82%,316.08k,,,,,,0.00%,"Nov 08, 2020",,5:8,"Nov 08, 2020","Dec 30, 2020","Mar 30, 2021",0.00%,-388.06%,-63.67%,"-1,608.40%",1.46M,0.22,164.70%,958.25k,-5.67M,-9.36M,,,8.42M,0.81,418.93k,7.48,5.15,,-5.65M,-1.82M,Value,34240,Healthcare,10,"INVO Bioscience, Inc., a medical device company, provides assisted reproductive technology solutions worldwide. It offers INVOcell, a patented intravaginal culture system used for the natural in vivo incubation of eggs and sperm during fertilization and early embryo development. The company was founded in 2007 and is based in Sarasota, Massachusetts.",Sarasota,978 878 9505,FL,1609372800,United States,http://www.invobioscience.com,86400,5582 Broadcast Court,Medical Devices
t-3,INVO,-3663564.0,10449000,34890,,-1322881,,-1322881,1252939,224902,-1062927,-1062927,,-259954,,,,0,246072,1308999,21170,-259954,,-1322881,-1322881,65400.0,23057085.0,5903925.0,-3598164.0,714286.0,2305761.0,790.0,-26656039.0,3214719.0,,1503951.0,1620969.0,199313.0,2041048.0,71199.0,244108.0,284460.0,,997911.0,-163850.0,-4595.0,2309510.0,-25794.0,11475052.0,1153951.0,-1150964.0,8547.0,-240.0,-81825.0,-67500.0,280224.0,-32674.0,2309510.0,-106316.0,-28733.0,420079.0,en-US,US,EQUITY,True,Delayed Quote,USD,us_market,3.92,1630526403,0.07000017,3.92,3.9215,3.8,12610,"INVO BioScience, Inc.",NCM,PRE,-0.08072854,0,False,False,1.8181863,3.8 - 3.9215,3.85,0.0,0.0,11,13,finmb_51592503,NasdaqCM,"INVO Bioscience, Inc.",USD,41364,25400,1.02,0.35172412,2.9 - 12.3,-8.38,-0.6813008,2.9,12.3,1604880000,1617134400,1617134400,1617134400,4,-0.78,-5.0256414,4.1314287,-0.21142864,-0.051175673,4.2642465,-0.3442464,40960080,15,America/New_York,EDT,-14400000,-1.15,,,12.3,2.9,4.1314,4.2642,41.36k,25.4k,10.45M,,8.22M,18.04%,15.72%,294.8k,4.88,2.90%,2.82%,316.08k,,,,,,0.00%,"Nov 08, 2020",,5:8,"Nov 08, 2020","Dec 30, 2020","Mar 30, 2021",0.00%,-388.06%,-63.67%,"-1,608.40%",1.46M,0.22,164.70%,958.25k,-5.67M,-9.36M,,,8.42M,0.81,418.93k,7.48,5.15,,-5.65M,-1.82M,Value,34240,Healthcare,10,"INVO Bioscience, Inc., a medical device company, provides assisted reproductive technology solutions worldwide. It offers INVOcell, a patented intravaginal culture system used for the natural in vivo incubation of eggs and sperm during fertilization and early embryo development. The company was founded in 2007 and is based in Sarasota, Massachusetts.",Sarasota,978 878 9505,FL,1609372800,United States,http://www.invobioscience.com,86400,5582 Broadcast Court,Medical Devices
